Stay updated on Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial page.

Latest updates to the Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedEnrollment is now closed, and new help sections have been added to guide users (How to Read a Study Record, Common Questions, How to Join a Study); the Intervention / Treatment header was reformatted to Intervention/Treatment and the revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check19 days agoChange DetectedThe study record now indicates Terminated with updated end-of-trial dates and related CTIS regulatory approvals. Previous status indicators such as 'Active, not recruiting' have been superseded by these administrative updates.SummaryDifference0.4%

- Check41 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating an updated page version. This appears to be a metadata update rather than a substantive change to content.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page’s displayed software revision/version was updated from **v3.5.2** to **v3.5.3**. This indicates a general site release with no apparent change to the trial’s study details.SummaryDifference0.0%

- Check70 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check98 days agoChange DetectedAdministrative updates to the page metadata (revision v3.5.0 and EU trial identifier 2018-000096-32) were applied. There were no changes to the study details, eligibility criteria, or outcomes.SummaryDifference0.3%

Stay in the know with updates to Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial page.